AGLIETTA, Massimo

AGLIETTA, Massimo  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 436 (tempo di esecuzione: 0.018 secondi).
Titolo Data di pubblicazione Autore(i) File
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients. 2012 Berger M; Grignani G; Giostra A; Ferrari S; Ferraresi V; Tamburini A; Cefalo G; Carnevale-Schianca F; Vassallo E; Picci P; Pagano M; Aglietta M; Pellerito RE; Fagioli F.
28th meeting of the Italian Cancer Society (SIC). New challenges of molecular oncology. 2002 LOLLINI PL; PIEROTTI MA; PASSERINI CG; BANI MR; ZUPI G; AGLIETTA M; ALBINI A
45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003 2004 GIAVAZZI R; AGLIETTA M; ASTOLFI A; FALANGA A; FUSCO A; LABIANCA R; LOLLINI PL; LOMBARDO C; NATALI PG; PIEROTTI MA; PRESTA M; SANTORO M; TARABOLETTI G; ZUPI G; VECCHIO G
[Diagnosis of neoplastic ascites: combined use of albumin gradient between serum and ascites and cholesterol in ascitic fluid] 1996 SARTORI M ;ANDORNO S ;BERMANI G ;COLOMBI S ;GAMBARO M ;LA TERRA G ;LEONE F ;MOLINARI GL ;AGLIETTA M
[Diagnostic approach to the anemic cancer patient] 1997 AGLIETTA M
[GM-CSF: target cells and their response kinetics] 1989 M. Aglietta; W. Piacibello; Aprá F; Stacchini A; Sanavio F; Monzeglio C;Mossetti C; F. Bussolino; Gavosto G.
[Lethal midline granuloma (LMG). Review of the literature and report of a case] 1990 BOCCA M ;AGLIETTA M ;PUGLISI A ;POMATTO E ;GHIGGIA M
[Prevalence of anemia in oncologic patients treated with chemotherapy. Italian survey at the national level] 2001 BERNARDO G ;AGLIETTA M ;AMADORI D ;BECCAGLIA P ;BELLI G ;BIANCO R ;CIONINI L ;COGNETTI F ;COLUCCI G ;COMELLA G ;DI COSTANZO F ;MARCHETTI P ;PRONZATO P
[Prevention and treatment of febrile neutropenia] 1997 MONTEMURRO F ;GALLICCHIO M ;AGLIETTA M
[The use of erythropoietin alpha in programs of high-dose chemotherapy] 2000 DANOVA M ;AGLIETTA M ;PIERELLI L ;FERRARI S ;PERILLO A ;SCAMBIA G ;HENRY D
A comparison of allografting with autografting for newly diagnosed myeloma 2007 BRUNO B; ROTTA M; PATRIARCA F; MORDINI N; ALLIONE B; CARNEVALE-SCHIANCA F; GIACCONE L; SORASIO R; OMEDE P; BALDI I; BRINGHEN S; MASSAIA M; AGLIETTA M; LEVIS A; GALLAMINI A; FANIN R; PALUMBO A; STORB R; CICCONE G; BOCCADORO M
A comparison of two GM-CSF schedules to counteract the granulo-monocytopenia of carboplatin-etoposide chemotherapy. 1995 TAFUTO S ;ABATE G ;D'ANDREA P ;SILVESTRI I ;MARCOLIN P ;VOLTA C ;MONTEVERDE A ;COLOMBI S ;ANDORNO S ;AGLIETTA M
A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma 2004 LEVIS A; PIETRASANTA D; GODIO L; VITOLO U; CIRAVEGNA G; DI VITO F; GAVAROTTI P; GUGLIELMELLI T; ORSUCCI L; RAVIOLO E; SCALABRINI DR; SALVI F;T ONSO A; AGLIETTA M; BOCCADORO M; GALLAMINI A; SAGLIO G; SCASSA E; GALLO E
A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer 2005 BUSSOLATI G; MONTEMURRO F; RIGHI L; DONADIO M; AGLIETTA M; SAPINO A
A novel multidrug‐resistant cell line from an italian intrahepatic cholangiocarcinoma patient 2021 Peraldo-neia C.; Massa A.; Vita F.; Basirico M.; Raggi C.; Bernabei P.; Ostano P.; Casorzo L.; Panero M.; Leone F.; Cavalloni G.; Aglietta M.
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 2021 Rovesti G.; Leone F.; Brandi G.; Cesario S.; Scartozzi M.; Niger M.; Yoo C.; Filippi R.; Casagrande M.; Silvestris N.; Santini D.; Faloppi L.; Palloni A.; Aglietta M.; Bernardini L.; Cho H.; Lai E.; Fenocchio E.; Pircher C.; Iacono D.; De Lorenzo S.; Sperti E.; Massa V.; De Braud F.; Jeong J.H.; Aprile G.; Burgio V.; Cascinu S.; Casadei-Gardini A.
A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: an Italian Sarcoma Group study. 2011 Grignani G; Palmerini E; Stacchiotti S; Boglione A; Ferraresi V; Frustaci S; Comandone A; Casali PG; Ferrari S; Aglietta M.
A phase I dose-escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer. 2014 Aglietta M;Barone C;Sawyer MB;Moore MJ;Miller WH Jr;Bagalà C;Colombi F;Cagnazzo C;Gioeni L;Wang E;Huang B;Fly KD;Leone F
A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer 2004 MONTEMURRO F; CHOA G; FAGGIUOLO R; DONADIO M; MINISCHETTI M; DURANDO A; CAPALDI A; VIETTI-RAMUS G; ALABISO O; AGLIETTA M
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. 2012 Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M.